OJAnes  Vol.3 No.8 , October 2013
Anaesthesia Management for Ablation Therapy in Post Heart Transplant Arrhythmia
Abstract: In this case series we describe the anaesthetic management of atrial ablation for arrhythmia in three post heart transplant patients. These patients provide a unique challenge to the anaesthesiologist, as heart physiology, end organs effects, procedural related factors should all be part of the specific anaesthetic plan tailored for each patient individually. The different anaesthetic techniques applied, and procedure related complications are evaluated. Anaesthetic management, procedural related difficulties, pharmacologic aspects, and possible associated complications are reviewed.
Cite this paper: S. Prapaitrakool, D. Bainbridge and R. Lavi, "Anaesthesia Management for Ablation Therapy in Post Heart Transplant Arrhythmia," Open Journal of Anesthesiology, Vol. 3 No. 8, 2013, pp. 349-352. doi: 10.4236/ojanes.2013.38074.

[1]   M. S. Mulligan, T. H. Shearon, D. Weill, F. D. Pagani, J. Moore and S. Murray, “Heart and Lung Transplantation in the United States, 1997-2006,” American Journal of Transplantation, Vol. 8, No. 4p2, 2008, pp. 977-987.

[2]   M. Vaseghi, N. G. Boyle, R. Kedia, J. K. Patel, D. A. Cesario, I. Wiener, J. A. Kobashigawa and K. Shivkumar, “Supraventricular Tachycardia After Orthotopic Cardiac Transplantation,” Journal of the American College of Cardiology, Vol. 51, No. 23, 2008, pp. 2241-2249.

[3]   S. A. L. Ahmari, T. J. Bunch, A. Chandra, V. Chandra, K. Ujino, R. C. Daly, S. S. Kushwaha, B. S. Edwards, Y. F. Maalouf, J. B. Seward, C. G. McGregor and K. Chandrasekaran, “Prevalence, Pathophysiology, and Clinical Significance of Post-Heart Transplant Atrial Fibrillation and Atrial Flutter,” The Journal of Heart and Lung Transplantation, Vol. 25, No. 1, 2006, pp. 53-60.

[4]   H. Oral, C. Scharf, A. Chugh, B. Hall, P. Cheung, E. Good, S. Veerareddy, F. Pelosi and F. Morady, “Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation versus Left Atrial Ablation,” 2003, pp. 2355-2360.

[5]   F. Rodríguez-Entem, V. Expósito, S. González-Enríquez, T. García-Camarero and J. Olalla, “Atrial Flutter after Heart Transplantation: Mechanism and Catheter Ablation,” Transplantation Proceedings, Vol. 42, No. 7, 2010, pp. 2697-2701.

[6]   J. A. Mariani, M. A. McDonald, K. Nanthakumar, J. D. Parker and H. J. Ross, “Cardiac Resynchronization Therapy after Atrioventricular Node Ablation for Rapid Atrial Fibrillation in a Heart Transplant Recipient with Late Allograft Dysfunction,” The Journal of Heart and Lung Transplantation, Vol. 29, No. 6, 2010, pp. 704-706.

[7]   A. Jeffrey and N. M. E. Morgan, “Orthotopic Cardiac Transplantation: Comparison of Outcome Using Biatrial, Bicaval, and Total Techniques,” Journal of Cardiac Surgery, Vol. 20, No. 1, 2005, pp. 102-106.

[8]   P. Lena, C. Mariottini, N. Balarac, J. Jacques Arnulf, A. Mihoubi and R. Martin, “Remifentanil versus Propofol for Radio Frequency Treatment of Atrial Flutter,” Canadian Journal of Anesthesia, Vol. 53, No. 4, 2006, pp. 357-362.

[9]   A. Natale, A. Raviele, T. Arentz, H. Calkins, S. Chen, M. Haissaguerre, G. Hindricks, Y. Ho, K. Kuck, F. Marchlinski, C. Napolitano, D. Packer, C. Pappone, E. Prystowsky, R. Schilling, D. Shah, S. Themistoclakis and A. Verma, “Venice Chart International Consensus Document on Atrial Fibrillation Ablation,” Journal of Cardiovascular Electrophysiology, Vol. 18, No. 5, 2007, pp. 560-580.

[10]   L. Blier, M. Gilbert, J. Villeneuve, D. Mohty and G. O’hara, “Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular Disease,” Pacing and Clinical Electrophysiology, Vol. 30, 2007, pp. 116-119.

[11]   G. B. Chierchia, L. Capulzini, C. de Asmundis, A. Sarkozy, M. Roos, G. Paparella, T. Boussy, G. Van Camp, D. Kerkhove and P. Brugada, “First Experience with Real-Time Three-Dimensional Transoesophageal Echocardiography-Guided Transseptal in Patients Undergoing Atrial Fibrillation Ablation,” 2008, pp. 1325-1328.